Mycosis fungoides
MONDO:0009691Classical mycosis fungoides is the most common type of mycosis fungoides (MF), a form of cutaneous T-cell lymphoma, and is characterized by slow progression from patches to more infiltrated plaques and eventually to tumors.
Also known as: CTCL/ mycosis fungoides, MF, cutaneous T-cell lymphoma/mycosis fungoides, mycosis fungoides, mycosis fungoides (morphologic abnormality), mycosis fungoides NOS (morphologic abnormality), mycosis fungoides of unspecified site, mycosis fungoides, Alibert-Bazin type
3197 clinical trials for this condition and its sub-types, 82 tagged with Mycosis fungoides itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Light-Activated gel shows promise for rare skin cancer
Disease control Stopped earlyThis Phase 3 trial tests a gel called HyBryte, which is activated by visible light, for treating cutaneous T-cell lymphoma (CTCL), a rare type of skin cancer. About 80 adults with early-stage CTCL will apply the gel or a placebo twice a week for 18 weeks, then receive light treat…
Phase 3 • Sponsor: Soligenix • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Promising lymphoma combo trial halted after just 8 patients
Disease control Stopped earlyThis early-phase trial tested two lab-made antibodies, magrolimab and mogamulizumab, together in people with a type of T-cell lymphoma (mycosis fungoides or Sezary syndrome) that had returned or stopped responding to prior treatments. The goal was to find the best dose and see if…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC